OBI Pharma, Inc., a Taiwan biopharma company (TPEx: 4174), today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation...
Tag - Lymphoblastic Leukemia
Press Releases
Timeless Medical Systems® appoints Mike Antonelli as VP of Technology to drive next-generation platform innovation
Luma acquires Tonic to support 1,000+ health systems and 100M patients
HealthTree adds Flatiron Health and CareSpace EHR connections
DSS Wins CTM Plus Contract from U.S. Department of Veterans Affairs
